CD274 and uterine corpus sarcoma: Together, these findings provide support for screening checkpoint proteins, such as PD1, PD-L1, IDO, and CTLA-4 in post-surgical uterine sarcomas as they provide the means for the utilization of targeted immunotherapies in these rare but aggressive uterine sarcomas.